Abstract
3/2021
vol. 17
Image in intervention
Very long-term follow-up after in-tunnel patent foramen ovale closure with FlatStent EF: still an attractive option?
- Centro Cardiologico Monzino, IRCCS, University of Milan, Milan, Italy
- Reparto di Cardiologia, Ospedale San Giuseppe Moscati, Avellino, Italy
- Centro di Cardiologia Interventistica, Istituto Clinico Sant’Ambrogio, Milan, Italy
- Department of Biomedical and Clinical Sciences, “Luigi Sacco”, University of Milan, Milan, Italy
Adv Interv Cardiol 2021; 17, 3 (65): 319–321
Online publish date: 2021/09/14
We present a case of a 38-year-old woman, aura migraineur, with a past medical history of Hashimoto’s thyroiditis and elevated homocysteine level of 75 µmol/l due to homozygous C677T MTHFR gene mutation on folic acid supplementation. In December 2009 a right-sided hemiparesis on awakening occurred and brain magnetic resonance imaging confirmed left thalamic infarct. Continuous ECG monitoring ruled out atrial fibrillation. A Doppler study of lower limbs revealed no overt thrombosis. Extracranial duplex ultrasound examination was normal and carotid dissection was excluded. Two-dimensional (2D) transthoracic/transesophageal echocardiography (TTE/TEE) color Doppler showed a right-to-left shunt (RLS) via a long tunnel-type patent foramen ovale (PFO), with an overlap between the primum and secundum septum of 13 mm along with a prominent Eustachian valve.
Indexed in
Integrated with
